amlodipine and benazepril hydrochloride
Generic: amlodipine and benazepril hydrochloride
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
amlodipine and benazepril hydrochloride
Generic Name
amlodipine and benazepril hydrochloride
Labeler
preferred pharmaceuticals inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
amlodipine besylate 10 mg/1, benazepril hydrochloride 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8454
Product ID
68788-8454_ee887783-3d4a-4eb5-af46-ca1807e5d7d3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202239
Listing Expiration
2027-12-31
Marketing Start
2023-06-02
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888454
Hyphenated Format
68788-8454
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
amlodipine and benazepril hydrochloride (source: ndc)
Generic Name
amlodipine and benazepril hydrochloride (source: ndc)
Application Number
ANDA202239 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/1
- 20 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (68788-8454-3)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ee887783-3d4a-4eb5-af46-ca1807e5d7d3", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342"], "spl_set_id": ["b25681a9-7b0e-40f9-844e-ec4842e3713c"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-8454-3)", "package_ndc": "68788-8454-3", "marketing_start_date": "20230602"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "68788-8454_ee887783-3d4a-4eb5-af46-ca1807e5d7d3", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "68788-8454", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20230602", "listing_expiration_date": "20271231"}